Last reviewed: July 3, 2026
Last updated: July 3, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Both semaglutide and tirzepatide reduce hunger and improve blood sugar control, but they work through different pathways in your body. Clinical trials show tirzepatide produces up to 22% body weight reduction, compared to 15% for semaglutide alone. Choosing between them depends on your metabolism, weight loss goals, and how your body responds to different peptide signals.
How Semaglutide and Tirzepatide Differ in Mechanism
Semaglutide activates only the GLP-1 receptor, a pathway that signals fullness to your brain and slows stomach emptying. Tirzepatide activates two receptors: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). This dual action means tirzepatide sends stronger appetite-suppression signals and may have additional metabolic benefits.
The GIP receptor pathway influences how your body handles glucose and fat storage. When both GLP-1 and GIP receptors are activated together, the combined effect can produce more significant weight loss and metabolic changes than either pathway alone. This is why many patients notice stronger results with tirzepatide, especially after their body adapts to the medication over several months.
Comparing Weight Loss Results: Clinical Trial Data
The SUSTAIN trials showed semaglutide users lost an average of 12–15% of body weight over 68 weeks at the highest doses. The SURMOUNT trials demonstrated tirzepatide users achieved 20–22% body weight loss in the same timeframe, with some patients losing even more. These differences suggest tirzepatide's dual-receptor action produces more robust fat loss, though individual results vary significantly.
The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
Side Effects and Tolerability Differences
Both medications cause similar common side effects: nausea, vomiting, constipation, and reduced appetite. Nausea typically peaks in the first 2–4 weeks and decreases as your body adjusts. Because tirzepatide is more potent, some patients report stronger initial nausea, while others tolerate it equally well or better than semaglutide.
Gastrointestinal side effects are usually dose-related and manageable through slow dose escalation and dietary adjustments. PlexusDx prescribers start at the lowest effective dose and increase gradually based on your tolerance and weight loss progress. If side effects become intolerable on one medication, switching to the other or trying a lower dose of a dual-compound formula (GLP-Squared) may provide better balance.
Choosing the Right Medication for Your Goals
Choose semaglutide if you want a proven single-action GLP-1 therapy, prefer potentially fewer side effects, or have successfully used it before. Semaglutide from PlexusDx starts at $189/month for the injection or $289/month for the oral form. It works well for patients with modest weight loss goals (10–15% reduction) or those new to GLP-1 therapy.
Choose tirzepatide if you need stronger hunger suppression, have a higher starting weight, or want maximum weight loss results. Tirzepatide injection from PlexusDx starts at $289/mo (or $249/mo on the 6-month plan), with the oral form at $279/month. It's ideal for patients who didn't respond adequately to semaglutide or who want the metabolic benefits of dual-receptor activation. PlexusDx also offers GLP-Squared Injection (semaglutide + tirzepatide combined) for $289/month for patients seeking synergistic effects.
Personalization Through Genetic Testing
The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R (rs17782313) — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.
PlexusDx's Precision Peptide Genetic Test ($99 add-on after your first month) analyzes these four key variants plus 46 additional peptide-pathway genes across 14 metabolic systems. This test reveals whether your body is primed to respond better to single-action semaglutide, dual-action tirzepatide, or a combination formula. Knowledge of your genetic profile helps your PlexusDx provider match you to the medication most likely to produce the fastest, safest weight loss for your unique biology.
How Your Genetics Relate to GLP-1 Pathways
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I switch from semaglutide to tirzepatide if I'm not losing weight fast enough?
Yes. Many patients successfully transition from semaglutide to tirzepatide after 8–12 weeks if results plateau or fall short of goals. Your PlexusDx provider can overlap doses briefly or switch directly, depending on your current semaglutide dose and tolerance. Tirzepatide's dual action often reignites weight loss in patients who have plateaued on semaglutide alone.
Which medication has more scientific evidence behind it?
Both have strong clinical trial data. Semaglutide (Ozempic) has longer real-world use history and broader insurance coverage, making it well-studied. Tirzepatide (Mounjaro) is newer but showed superior weight loss results in head-to-head trials, with FDA approval for chronic weight management. Both are evidence-based, but tirzepatide's dual mechanism represents a newer advance in peptide therapy.
Is there a price difference between semaglutide and tirzepatide at PlexusDx?
Compounded semaglutide injection starts at $189/mo (or $149/mo on the 6-month plan), while tirzepatide injection starts at $289/mo (or $249/mo on the 6-month plan). Both are flat-rate pricing regardless of dose—your dose may increase, but your monthly cost stays the same. All PlexusDx medications are HSA/FSA eligible and require no insurance or membership fees, making either option accessible across all 50 states.
Are compounded semaglutide and tirzepatide as safe as brand-name versions?
PlexusDx sources all compounded medications from licensed 503A compounding pharmacies, which follow strict FDA quality standards for sterility, potency, and purity. While compounded medications are not FDA-approved branded products, 503A compounded peptides are legal, regulated, and widely used in clinical practice. Your PlexusDx provider monitors your progress and safety just as they would with brand-name Ozempic or Mounjaro.
Should I get the Precision Peptide Genetic Test before choosing semaglutide or tirzepatide?
Genetic testing is optional but valuable. You can start with either medication and add the test after your first month for $99. The Precision Peptide Genetic Test analyzes 49 peptide genes and 14 metabolic pathways to reveal whether your GLP1R, GIPR, FTO, and MC4R variants favor semaglutide, tirzepatide, or a combination approach. This insight helps optimize your medication choice and can accelerate results if you haven't found the right fit yet.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Will I Gain Weight If I Stop Taking Ozempic?
Navigating Your Wellness: Can I Take Ashwagandha with Wegovy?